(Q48762576)

English

Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics

scientific article published on April 1, 1991

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/1709331

Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics (English)

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

0 references

0 references

Carl-Gerhard Gottfries

3

object named as

Gottfries CG

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/1709331

author name string

S. O. Frederiksen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1709331

4 November 2022

R. Ekman

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1709331

4 November 2022

C. G. Gottfries

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1709331

4 November 2022

E. Widerlöv

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1709331

4 November 2022

S. Jonsson

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1709331

4 November 2022

language of work or name

0 references

publication date

1 April 1991

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/1709331

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0447.1991.tb05539.x

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.1991.tb05539.x/fullpdf

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Acta Psychiatrica Scandinavica

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/1709331

83

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/1709331

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/1709331

273-277

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/1709331

Post-mortem study of chronic schizophrenic brains

1

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Is there gliosis in schizophrenia? Investigation of the temporal lobe

2

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses

3

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Increased dopamine-receptor sensitivity in schizophrenia

4

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

5

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

DOPAMINE RECEPTOR ASYMMETRY IN SCHIZOPHRENIA

6

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

7

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

8

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Brain tryptophan metabolism in schizophrenia: A post mortem study of metabolites on the serotonin and kynurenine pathways in schizophrenic and control subjects

9

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Monoamines and monoamine metabolites in brains from demented schizophrenics

10

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients

11

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

12

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics

13

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Neuropeptides, dopamine, and schizophrenia

14

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Increased CSF levels of endorphines in chronic psychosis

15

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Endorphins in human cerebrospinal fluid: Clinical correlations to some psychotic states

16

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment

20

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Reduced CSF neurotensin concentration in drug-free schizophrenic patients

21

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.

22

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Delta-sleep inducing peptide in cerebrospinal fluid from schizophrenics, depressives and healthy volunteers

23

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively

24

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Radioimmunoassay of delta sleep-inducing peptide using an iodinated p-hydroxyphenylpropionic acid derivative as tracer

25

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Peptide YY-like immunoreactivity in the central nervous system of the rat.

26

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Arginine vasopressin, but not corticotropin releasing factor, is a potent stimulator of adrenocorticotropic hormone following electroconvulsive treatment

27

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Neuropeptides in the human appendix. Distribution and motor effects

28

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Hormones, dopamine receptors and schizophrenia

29

1 reference

10.1111/J.1600-0447.1991.TB05539.X

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB05539.X

4 November 2022

Identifiers

10.1111/J.1600-0447.1991.TB05539.X

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/1709331

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/1709331

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48762576&oldid=1764653910"